IL71318A - (1h-tetrazol-5-yl)tetrazolo(1,5-a)quinolines and related compounds,their preparation and antiallergic pharmaceutical compositions containing them - Google Patents

(1h-tetrazol-5-yl)tetrazolo(1,5-a)quinolines and related compounds,their preparation and antiallergic pharmaceutical compositions containing them

Info

Publication number
IL71318A
IL71318A IL71318A IL7131884A IL71318A IL 71318 A IL71318 A IL 71318A IL 71318 A IL71318 A IL 71318A IL 7131884 A IL7131884 A IL 7131884A IL 71318 A IL71318 A IL 71318A
Authority
IL
Israel
Prior art keywords
tetrazolo
quinolines
tetrazol
related compounds
preparation
Prior art date
Application number
IL71318A
Other languages
English (en)
Other versions
IL71318A0 (en
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL71318A0 publication Critical patent/IL71318A0/xx
Publication of IL71318A publication Critical patent/IL71318A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Luminescent Compositions (AREA)
IL71318A 1983-03-25 1984-03-22 (1h-tetrazol-5-yl)tetrazolo(1,5-a)quinolines and related compounds,their preparation and antiallergic pharmaceutical compositions containing them IL71318A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/478,964 US4496569A (en) 1983-03-25 1983-03-25 Antiallergic (1H-tetrazol-5-yl)tetrazolo[1,5-a]quinolines and derivatives thereof

Publications (2)

Publication Number Publication Date
IL71318A0 IL71318A0 (en) 1984-06-29
IL71318A true IL71318A (en) 1986-11-30

Family

ID=23902115

Family Applications (1)

Application Number Title Priority Date Filing Date
IL71318A IL71318A (en) 1983-03-25 1984-03-22 (1h-tetrazol-5-yl)tetrazolo(1,5-a)quinolines and related compounds,their preparation and antiallergic pharmaceutical compositions containing them

Country Status (19)

Country Link
US (1) US4496569A (xx)
EP (1) EP0120484B1 (xx)
JP (1) JPS59176287A (xx)
KR (1) KR900003649B1 (xx)
AT (1) ATE26717T1 (xx)
AU (1) AU558762B2 (xx)
CA (1) CA1252100A (xx)
DE (1) DE3463271D1 (xx)
DK (1) DK165694C (xx)
ES (1) ES8601970A1 (xx)
GR (1) GR81463B (xx)
IE (1) IE57072B1 (xx)
IL (1) IL71318A (xx)
MX (1) MX9203341A (xx)
NO (1) NO161067C (xx)
NZ (1) NZ207582A (xx)
PH (1) PH20353A (xx)
PT (1) PT78288B (xx)
ZA (1) ZA842067B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4014171A1 (de) * 1990-05-03 1991-11-07 Basf Ag Cyanochinolinverbindungen
CN1043644C (zh) * 1994-03-25 1999-06-16 默里尔药物公司 制备(1H-四唑-5-基)四唑并[1,5-a]喹啉和1,8-二氮杂萘的方法
JP3674407B2 (ja) 1999-09-21 2005-07-20 ヤマハ株式会社 演奏データ編集装置、方法及び記録媒体
JP2007506788A (ja) * 2003-09-26 2007-03-22 ライジェル ファーマシューティカルズ, インコーポレイテッド Hcv感染阻害剤とその使用法
WO2005121138A2 (en) * 2004-06-03 2005-12-22 Rigel Pharmaceuticals, Inc. Heterotricyclic compounds for use as hcv inhibitors
KR101101950B1 (ko) * 2011-11-04 2012-01-02 이동진 왕복 페달식 자전거

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3764681A (en) * 1970-07-08 1973-10-09 Lilly Co Eli Certain tetrazolo-(1,5-a) quinoline compounds as fungus control agents
US4035368A (en) * 1975-04-02 1977-07-12 Riker Laboratories, Inc. Substituted 3-(1H-tetrazol-5-yl)-quinoline compounds

Also Published As

Publication number Publication date
IE57072B1 (en) 1992-04-22
ES530876A0 (es) 1985-11-01
NZ207582A (en) 1986-10-08
ZA842067B (en) 1984-10-31
DK165694C (da) 1993-06-07
US4496569A (en) 1985-01-29
EP0120484B1 (en) 1987-04-22
PT78288A (en) 1984-04-01
EP0120484A1 (en) 1984-10-03
KR900003649B1 (ko) 1990-05-28
ATE26717T1 (de) 1987-05-15
NO161067C (no) 1989-06-28
NO161067B (no) 1989-03-20
MX9203341A (es) 1992-08-01
AU558762B2 (en) 1987-02-05
PH20353A (en) 1986-12-04
DK165584A (da) 1984-09-26
KR840008156A (ko) 1984-12-13
DK165694B (da) 1993-01-04
GR81463B (xx) 1984-12-11
JPS59176287A (ja) 1984-10-05
PT78288B (en) 1986-04-22
DE3463271D1 (en) 1987-05-27
JPH0415791B2 (xx) 1992-03-19
CA1252100A (en) 1989-04-04
NO841156L (no) 1984-09-26
AU2595384A (en) 1984-09-27
DK165584D0 (da) 1984-03-23
IL71318A0 (en) 1984-06-29
ES8601970A1 (es) 1985-11-01
IE840719L (en) 1984-09-25

Similar Documents

Publication Publication Date Title
ZA869748B (en) N-containing fused heterocyclic compounds,processes for the preparation thereof and pharmaceutical composition comprising the same
PH17158A (en) Imidazo(1,2-a)pyridin-2-yl carbostyril derivatives and compositions containing same
EP0124314A3 (en) Substituted-3H-indeno(1,2-c)pyridazin-3-ones
JO1406B1 (en) Chemical compounds
IL71319A (en) (1h-tetrazol-5-yl)-2(1h)-quinolinones,process for their preparation and pharmaceutical compositions containing the same
IL71318A (en) (1h-tetrazol-5-yl)tetrazolo(1,5-a)quinolines and related compounds,their preparation and antiallergic pharmaceutical compositions containing them
DK0481274T3 (xx)
IE831145L (en) Pyridine derivatives
DK161384C (da) Pyrazolooe3,4,5-klaaacridinforbindelser og farmaceutiske praeparater indeholdende saadanne forbindelser
DE3478437D1 (en) Pyrazolo(1,5-a)pyridine derivatives and compositions containing them
ATE41003T1 (de) Tetrazolothienopyridine.
IL83088A0 (en) Substituted 3-isoquinolinols,their preparation and pharmaceutical compositions containing them
ES8505357A1 (es) Un procedimiento para la preparacion de derivados de carboxi-tiazolo (3,2-a) pirimidina nuevos
IL67400A (en) Octahydro-3,7a-diazacyclohepta(j,k)fluorene derivatives,their preparation and pharmaceutical compositions containing them
DE3576076D1 (de) (tetrazolyl)thienopyridone.
AU6740187A (en) Heterocyclic compounds, methods for the manufacture of the same and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees
HC Change of name of proprietor(s)

Owner name: AVENTIS INC.

Free format text: FORMER NAME:MERRELL PHARMACEUTICALS INC.